Cancer-associated thrombosis: updates and controversies.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2012, Issue , 2012, Pages 626-630

  Khorana, Alok A ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; THROMBOPLASTIN;

CELL COUNT; CHEMISTRY; CYTOLOGY; HEMATOLOGY; HUMAN; LEUKOCYTE; METABOLISM; METHODOLOGY; NEOPLASM; OUTPATIENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; BIOLOGICAL MARKERS; CELL COUNT; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMATOLOGY; HUMANS; LEUKOCYTES; NEOPLASMS; OUTPATIENTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; THROMBOPLASTIN; THROMBOSIS; VENOUS THROMBOEMBOLISM;

MLCS; MLOWN;

EID: 84878484350     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation.v2012.1.626.3798655     Document Type: Review

References (0)